XENOREX

USPTO USPTO 2000 ABANDONED - AFTER PUBLICATION

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark XENOREX was filed as Word mark on 06/14/2000 at the U.S. Patent and Trademark Office. The current status of the mark is "ABANDONED - AFTER PUBLICATION".

Trademark Details Last update: August 1, 2019

Trademark form Word mark
File reference 76070842
Application date June 14, 2000
Publication date January 8, 2002

Trademark owner

9393 Towne Centre Drive, Suite 200
92121 San Diego
US

Trademark representatives

goods and services

1 Biochemicals, namely, monoclonal antibodies and fragments thereof for research and development, and manufacturing pharmaceuticals; and cell lines for use in the manufacture of pharmaceuticals
5 Biochemicals, namely, monoclonal antibodies and fragments thereof for clinical, diagnostic and therapeutic use for the treatment of cancer, infectious diseases, inflammatory diseases, and genetic diseases; and cell lines for clinical, diagnostic and therapeutic use for the treatment of cancer, infectious diseases, inflammatory diseases, and genetic diseases
31 Animal embryos for laboratory use; and live animals for research and development
42 Pharmaceutical and biological product development consultation; and pharmaceutical and biological product development for others

ID: 1376070842